TGFB1 and neoplasm: In this study, we demonstrate that patients with ICC that express high levels of TGF-β1 have a higher chance of tumour recurrence, lymph node metastasis, lymphovascular invasion and distant metastasis than those with tumours that lack TGF-β1 expression.